COMMUNIQUÉS West-GlobeNewswire

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/04/2026
BRISBANE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on April 8, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera [...]
ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility
10/04/2026
New 2026 Program Overview Details Compounded NAD+ Therapy Access, Three-Entity Telehealth Structure, and What Patients Should Know Before Starting Clinician-Reviewed Prescription NAD+ Programs Cheyenne, WY, April 10, [...]
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
10/04/2026
ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference. Iradimed’s CFO, Jack Glenn, will [...]
Pelthos Therapeutics Announces CFO Transition
10/04/2026
Senior Vice President, Finance & Accounting John M. Gay named Chief Financial Officer DURHAM, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company [...]
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
10/04/2026
WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026
10/04/2026
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering
10/04/2026
OCEANSIDE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the [...]
Matricis.ai Launches First U.S. Clinical Pilot of EndomAI for AI-Assisted Detection of Endometriosis with SimonMed
10/04/2026
Collaboration marks the first clinical pilot of AI-assisted MRI analysis for endometriosis. Paris, France, April 10, 2026 (GLOBE NEWSWIRE) -- Matricis.ai, a healthcare technology company developing artificial [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2026
10/04/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: First-Quarter 2026 Revenue Conference Call Invitation
10/04/2026
First-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our First-Quarter 2026 Revenue [...]
EssilorLuxottica: First-Quarter 2026 Revenue Conference Call Invitation
10/04/2026
First-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our First-Quarter 2026 Revenue [...]
EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS
10/04/2026
2025 ANNUAL RESULTS Annual revenue up 9% to €168 million Roll-out of the Group’s strategy: Sales of proprietary products up 20%, accounting for 35% of revenue Internationalisation: 42% of revenue generated outside [...]
Humber River Health Renames Wilson Site Hennick Humber Hospital Following Transformational $50 Million Gift
10/04/2026
Landmark philanthropic investment from the Hennick Family Foundation will accelerate innovation and patient care at North America’s first fully digital hospital TORONTO, April 10, 2026 (GLOBE NEWSWIRE) -- Humber River [...]
EUROBIO SCIENTIFIC : RESULTAT ANNUEL 2025
10/04/2026
RESULTAT ANNUEL 2025 Progression du chiffre d’affaires annuel de 9% à 168 M€ Déploiement de la stratégie du Groupe : Ventes des produits propriétaires en hausse de 20%, à 35% du Chiffre d’affaires Internationalisation [...]
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
10/04/2026
Targets $81B command-and-control and video analytics markets by 2030, driven by real-time situational awareness in defense environments NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc [...]
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
10/04/2026
Financing secures path to first NDA submission for buntanetap 6-Month symptomatic data readout anticipated Q1 2027 Alzheimer’s disease Phase 3 trial 75% enrolled Parkinson's disease open-label study 28% enrolled MALVERN [...]
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
10/04/2026
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- [...]
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
10/04/2026
Preclinical models demonstrate potential to restore thymic function lost with aging reducing susceptibility to cancer, autoimmune diseases, infections, and reduced vaccine efficacy HOUSTON, April 10, 2026 (GLOBE [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space
10/04/2026
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- via AINewsWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by AINewsWire ("AINW"), one of 75+ brands within the [...]

Pages